(109 days)
Sterile Hypodermic Syringe with/without needle: The Sterile Hypodermic Syringe with/without needle is intended for use in the aspiration and injection of fluids for medical purposes.
Sterile Hypodermic Needle: The Sterile Hypodermic Needle is intended to be used with a syringe for fluids aspiration and injection for medical purposes.
The Sterile Hypodermic Syringe with/without needle is intended for use in the aspiration and injection of fluids for medical purposes. The Sterile Hypodermic Needle is intended to be used with a syringe for fluids aspiration and injection for medical purposes. It is intended for the patient population, including adults, transitional adolescents, adolescents, and children. The device is intended for use in a professional healthcare facility. The device is a disposable syringe made of the following components: Needle cap, Needle tube, Needle hub, Barrel, Plunger, Plunger stopper.
The provided submission describes a medical device, a Sterile Hypodermic Syringe with/without Needle and a Sterile Hypodermic Needle, and does not involve AI/ML. Therefore, the requested information regarding acceptance criteria and studies that prove the device meets these criteria in the context of AI/ML, human readers, ground truth, and sample sizes for training/test sets is not applicable to this document.
The document focuses on demonstrating substantial equivalence to a predicate device through non-clinical performance testing, biocompatibility testing, sterilization validation, and package/shelf-life testing. No clinical data was submitted.
However, based on the non-clinical performance testing sections, I can extract the acceptance criteria and the studies performed to meet them as they relate to the physical device properties.
1. Table of Acceptance Criteria and Reported Device Performance
| Acceptance Criteria Category | Specific Standard/Test | Reported Device Performance |
|---|---|---|
| Performance | ISO 7886-1 (Sterile hypodermic syringes for single use - Part 1: Syringes for manual use) | Complied with standard requirements |
| ISO 9626 (Stainless steel needle tubing for the manufacture of medical devices - Requirements and test methods) | Complied with standard requirements | |
| ISO 7864 (Sterile hypodermic needles for single use -- Requirements and test methods) | Complied with standard requirements | |
| ISO 80369-7 (Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications) | Complied with standard requirements | |
| ISO 80369-20 (Small-bore connectors for liquids and gases in healthcare applications part 20: standard test methods) | Complied with standard requirements | |
| ISO 6009 (Hypodermic needles for single use Colour coding for identification) | Complied with standard requirements | |
| Biocompatibility | ISO 10993-5: 2009 (In Vitro Cytotoxicity) | Conforms to standard |
| ISO 10993-10: 2010 (Sensitization) | Conforms to standard | |
| ISO 10993-10: 2010 (Intracutaneous Reactivity) | Conforms to standard | |
| ISO 10993-11: 2017 (Acute Systemic Toxicity) | Conforms to standard | |
| ISO 10993-4:2017 (Coagulation) | Conforms to standard | |
| ISO 10993-4: 2017 (Complement activity) | Conforms to standard | |
| ISO 10993-4: 2017 & ASTM F756-17 (Hemolytic Properties) | Conforms to standard | |
| Sterilization Validation | ISO 11135-1 (Sterilization of health care products - ethylene oxide - part 1) | Complied with standard requirements |
| ISO 11737-1 (Sterilization of medical devices-Microbiological methods-Part 1) | Complied with standard requirements | |
| ISO 11737-2 (Sterilization of medical devices -- Microbiological methods -- Part 2) | Complied with standard requirements | |
| ISO 10993-7 (Biological evaluation of medical devices - Part 7: Test of Ethylene Oxide Residuals) | Complied with standard requirements | |
| AAMI / ANSI ST72 (Bacterial endotoxins - Test methods, routine monitoring, and alternatives to batch testing) | Complied with standard requirements | |
| Package and Shelf Life | AAMI/ANSI/ISO 11137-1 (Sterilization of health care products - Radiation - Part 1) | Complied with standard requirements |
| AAMI/ANSI/ISO 11737-2 (Sterilization of medical devices - Microbiological methods - Part 2) | Complied with standard requirements | |
| AAMI/ANSI/ISO 11607-1 (Packaging for terminally sterilized medical devices - Part 1) | Complied with standard requirements | |
| ASTM F1929-15 (Detecting Seal Leaks in Porous Medical Packaging by Dye Penetration) | Complied with standard requirements | |
| ASTM F1980-16 (Accelerated Aging of Sterile Barrier Systems for Medical Devices) | Complied with standard requirements | |
| ASTM D3078-02 (2021) (Determination of Leaks in Flexible Packaging by Bubble Emission) | Complied with standard requirements | |
| DIN58953-6: 2016 (Microbial barrier testing of packaging materials) | Complied with standard requirements | |
| ASTM F88/F88M-15 (Seal Strength of Flexible Barrier Materials) | Complied with standard requirements | |
| Package Integrity Tests | Accelerated Aging Test | Conducted |
| Simulated shipping distribution testing | Conducted | |
| Visual inspection | Conducted | |
| Performance Inspection (Chemical and Physical) | Conducted | |
| Sterile Test | Conducted | |
| Vacuum Leak Test | Conducted | |
| Dye penetration test | Conducted | |
| Agar Contact-Attack Test | Conducted | |
| Tensile Seal Strength Test | Conducted |
The remaining requested information is not applicable to this document as it pertains to AI/ML device studies, which this submission is not.
2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)
- Not applicable as this is a traditional medical device (syringe/needle) and not an AI/ML device. Performance testing for traditional devices typically involves testing physical samples defined by the relevant standards, not a "test set" of data in the AI/ML sense. No specific country of origin or retrospective/prospective nature of data for these tests is mentioned beyond the manufacturing location (China).
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)
- Not applicable as this is not an AI/ML device study. Ground truth in this context would refer to the validated methods and accepted performance limits defined by the referenced international standards, rather than expert consensus on data interpretation.
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
- Not applicable as this is not an AI/ML device study.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
- Not applicable as this is not an AI/ML device study. No human reader studies are mentioned.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
- Not applicable as this is not an AI/ML device study.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
- For the non-clinical performance, biocompatibility, sterilization, and packaging tests, the "ground truth" is defined by the objective pass/fail criteria and methodologies outlined in the referenced international and national consensus standards (e.g., ISO, ASTM, AAMI/ANSI). These standards represent established scientific and engineering principles for evaluating medical device safety and performance.
8. The sample size for the training set
- Not applicable as this is not an AI/ML device study.
9. How the ground truth for the training set was established
- Not applicable as this is not an AI/ML device study.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square and the words "U.S. Food & Drug Administration".
November 4, 2022
Anhui Hongyu Wuzhou Medical Manufacturer Co., Ltd % Charles Mack Principal Engineer Irc 2950 E Lindrick Drive Chandler, Arizona 85249
Re: K222124
Trade/Device Name: Sterile Hypodermic Syringe with/without Needle, Sterile Hypodermic Needle Regulation Number: 21 CFR 880.5860 Regulation Name: Piston Syringe Regulatory Class: Class II Product Code: FMF, FMF, FMI Dated: August 3, 2022 Received: August 8, 2022
Dear Charles Mack:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's
{1}------------------------------------------------
requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Alan M.
Stevens -S3
CAPT Alan M. Stevens Assistant Director DHT3C: Division of Drug Delivery and General Hospital Devices, and Human Factors OHT3: Office of GastroRenal, ObGyn, General Hospital and Urology Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
K222124
Device Name Sterile Hypodermic Syringe with/without needle Sterile Hypodermic Needle
Indications for Use (Describe)
Sterile Hypodermic Syringe with/without needle
The Sterile Hypodermic Syringe with/without needle is intended for use in the aspiration and injection of fluids for medical purposes.
Sterile Hypodermic Needle
The Sterile Hypodermic Needle is intended to be used with a syringe for fluids aspiration and injection for medical purposes.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| ------------------------------------------------- | -- |
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Image /page/3/Picture/0 description: The image contains a logo and text. The logo is on the left side of the image and consists of a red plus sign and a blue stylized letter "m". To the right of the logo is the text "安徽宏宇五洲医疗器械股份有限公司 ANHUI HONGYU WUZHOU MEDICAL MANUFACTURER CO., LTD". The text is in both Chinese and English.
K222124 510(k) SUMMARY
| Preparation Date: | November 4, 2022 |
|---|---|
| Manufacturer's Name and Address: | Anhui Hongyu Wuzhou MedicalManufacturer Co., Ltd.No. 2 Guanyin Road, Economic DevelopmentZone, Taihu, Anqing City, Anhui Province, China246400 |
| Corresponding Official: | Charles Mack |
| Telephone Number: | 931-625-4938 |
| Email Address: | charliemack@irc-us.com |
| Trade Name: | Sterile Hypodermic Syringewith/without NeedleSterile Hypodermic Needle |
| Common Name(s): | syringe, piston |
| Regulation Name(s): | Piston Syringe |
| Regulation Number(s): | 21CFR 880.5860 |
| Product Code: | FMF, FMI |
| Device Class: | Class II |
| Predicate Device: | K060211Anhui Hongyu Wuzhou MedicalManufacturer Co., Ltd. |
{4}------------------------------------------------
Device Description:
The Sterile Hypodermic Syringe with/without needle is intended for use in the aspiration and injection of fluids for medical purposes.
The Sterile Hypodermic Needle is intended to be used with a syringe for fluids aspiration and injection for medical purposes.
It is intended for the patient population, including adults, transitional adolescents, adolescents, and children.
The device is intended for use in a professional healthcare facility.
Warning: MR-unsafe!
Do not expose the device to a magnetic resonance (MR) environment.
- -The device may present a risk of projectile injury due to the presence of ferromagnetic materials that can be attracted by the MR magnet core.
- -Thermal injury and burns may occur due to the metal components of the device that can heat during MR scanning.
- -The device may generate artifacts in the MR image.
- -The device may not function properly due to the strong magnetic and radio frequency fields generated by the MR scanner.
The device is a disposable syringe made of the following components:
Needle cap: Covers the needle tube until the syringe is used.
Needle tube: The needle tube penetrates the patient's skin to inject/withdraw fluid from the body.
Needle hub: The needle hub is connected to the syringe by a 6% luer connector, which is colored to distinguish the gauge of the needle.
Barrel: The barrel has a scale showing the capacity of the syringe. It is connected to the Hypodermic Needle by a 6% luer connector.
Plunger: Assembled with the plunger stopper to inject/withdraw fluid from the body. Plunger stopper: Sealing when injecting/withdrawing fluid from the body.
{5}------------------------------------------------
Indications for Use
Sterile Hypodermic Syringe with/without needle
The Sterile Hypodermic Syringe with/without needle is intended for use in the aspiration and injection of fluids for medical purpose.
Sterile Hypodermic Needle
The Sterile Hypodermic Needle is intended to be used with a syringe for fluids aspiration and injection for medical purposes.
{6}------------------------------------------------
| Item | Subject Device | Predicate Device (own) | Discussion |
|---|---|---|---|
| 510(k) | Pending | K060211 | - |
| Manufacturer | Anhui Hongyu Wuzhou MedicalManufacturer Co., Ltd. | Anhui Hongyu WuzhouMedical ManufacturerCo., Ltd. | - |
| Name | Sterile Hypodermic Syringewith/without needleSterile Hypodermic Needle | Wuzhou Syringewith/without Needle | - |
| Product code | FMF, FMI | FMF, FMI | - |
| Indication for Use | Sterile Hypodermic Syringewith/without needleThe Sterile Hypodermic Syringewith/without needle is intended foruse in the aspiration and injection offluids for medical purposes.Sterile Hypodermic NeedleThe Sterile Hypodermic Needle isintended to be used with a syringe forfluids aspiration and injection formedical purposes. | The Wuzhou Syringe,with/without a needle isintended to be used formedical purposes toinject fluids into orwithdraw fluids from thebody. | Note 0 |
| Item | Subject Device | Predicate Device (own) | Discussion |
| Operation Mode | Manual use only | Manual use only | Identical |
| Label/Labeling | Complied with 21 CFR part 801 | Complied with 21 CFR part 801 | Identical |
| Material | PP, Stainless Steel, Rubber Piston | PP, Stainless Steel, Rubber Piston | Identical |
| Needle Length | 1/6"-2" | 1/6" ~ 1 1/2" | Note 1 |
| Syringe Volume | 1,2,2.5,3,5,10,20,30,50,60,100 ml | 1,2,5,10,20,30,50,60,100 ml | Note 2 |
| Needle Gauge | 15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30G | 16,18,20,21,22,23,24,25,26G | Note 3 |
| Needle Hub | Color-coded per ISO 6009 | Color-coded per ISO 6009 | Note 4 |
| Performance | Complied with the current applicableperformance standards:- ISO 9626- ISO 7864- ISO 80369-7- ISO 80369-20- ISO 7886-1 | Complied with the current applicableperformance standards:- ISO 9626- ISO 7864- ISO 594-1- ISO 594-2- ISO 7886-1 | Note 5 |
| Single Patient Use | Yes | Yes | Identical |
| Biocompatibility | Conforms to ISO 10993-1 | Conforms to ISO 10993-1 | Identical |
| How Supplied | SterileSingle Patient Use | SterileSingle Patient Use | Identical |
| Sterilization | EO | EO | Identical |
| SAL | 10-6 | 10-6 | Identical |
{7}------------------------------------------------
{8}------------------------------------------------
Note 0: Indication for Use
The Indications for Use for the subject device is slightly different from the predicate device. The intended use is the same for both devices.
Note 1: Needle Length
The needle length of the subject devices is available in more sizes than the predicate device. The difference does not raise new questions on the safety and effectiveness of the proposed device.
Note 2: Syringe Volume
The subject devices' syringe volume is different than the predicate device but is within the same range. The difference does not raise new questions about the safety and effectiveness of the proposed device.
Note 3: Needle Gauge
The needle gauge of the subject devices is a more different from the predicate device. The difference does not raise new questions about the safety and effectiveness of the proposed device.
Note 4: Needle Hub
The needle hub's material and colorant of the subject device is identical to the predicate device and all conform to ISO 6009 and ISO 10993.
Note 5: Performance
The subject device conforms to the current FDA recognize standards ISO80369-7 and ISO80369-20, which will replace ISO594-1 and ISO594-2.
{9}------------------------------------------------
Performance Testing
To establish substantial equivalence to the identified predicate device, we performed the tests noted below on the subject devices. The testing results proved that the device complies with the applicable standards requirement and is substantially equivalent to the predicate devices.
Non-Clinical Performance Testing
Testing was performed to evaluate the functional performance and safety of the subject device with the following standards:
Performance:
- ISO 7886-1 Second edition 2017-05 Sterile hypodermic syringes for single use - - Part 1: Syringes for manual use
- ISO 9626 Second edition 2016-08-01 Stainless steel needle tubing for the manufacture of medical devices - Requirements and test methods
- ISO 7864 Fourth edition 2016-08-01 Sterile hypodermic needles for single use --Requirements and test methods
- -ISO 80369-7 First edition 2016-10-15 Small-bore connectors for liquids and gases in healthcare applications - Part 7: Connectors for intravascular or hypodermic applications
- ISO 80369-20 First edition 2015-05-15, small-bore connectors for liquids and gases in healthcare applications part 20: standard test methods. (General I (QS/RM))
- ISO 6009 Fourth edition 2016-08-01 Hypodermic needles for single use Colour coding for identification
{10}------------------------------------------------
Biocompatibilitv
The subject device is classified as an external communication device → Circulating Blood -> Limited Contact Duration (≤24h). ISO 10993-5: 2009 In Vitro Cytotoxicity ISO 10993-10: 2010 Sensitization ISO 10993-10: 2010 Intracutaneous Reactivity ISO 10993-11: 2017 Acute Systemic Toxicity ISO 10993-4:2017 Coagulation ISO 10993-4: 2017 Complement activity
ISO 10993-4: 2017 & ASTM F756-17: Hemolytic Properties
Sterilization Validation:
ISO11135-1:Sterilization of health care products - ethylene oxide - part 1: requirements for the development, validation, and routine control of a sterilization process for medical devices.
ISO11737-1:Sterilization of medical devices-Microbiological methods-Part 1:
Determination of the population of microorganisms on product.
ISO11737-2: Sterilization of medical devices -- Microbiological methods -- Part 2: Tests of sterility performed in the validation of a sterilization process.
ISO 10993-7: Biological evaluation of medical devices - Part 7: Test of Ethylene Oxide Residuals.
AAMI / ANSI ST72: Bacterial endotoxins - Test methods, routine monitoring, and alternatives to batch testing.
Package and Shelf Life:
Applicable Standards:
AAMI/ANSI/ISO 11137-1:2006/(R) 2010 Sterilization of health care products -Radiation - Part 1: Requirements for development, validation, and routine control of a sterilization process for medical devices
AAMI/ANSI/ISO 11737-2:2009 Sterilization of medical devices - Microbiological methods - Part 2: Tests of sterility performed in the definition, validation, and maintenance of a sterilization process
AAMI/ANSI/ISO 11607-1:2006/(R) 2010 Packaging for terminally sterilized medical devices - Part 1: Requirements for materials, sterile barrier systems, and packaging systems, 3ed.
ASTM F1929-15 Standard Test Method for Detecting Seal Leaks in Porous Medical Packaging by Dye Penetration
{11}------------------------------------------------
ASTM F1980-16 Standard Guide for Accelerated Aging of Sterile Barrier Systems for Medical Devices
ASTM D3078-02 (2021), Standard Test Method for Determination of Leaks in Flexible Packaging by Bubble Emission. (Sterility)
DIN58953-6: 2016 Sterilization - Sterile supply - Part 6: Microbial barrier testing of packaging materials for medical devices which are to be sterilized.
ASTM F88/F88M-15 Standard Test Method for Seal Strength of Flexible Barrier Materials
The package integrity test noted below was conducted for the sterilization package of the subject devices by accelerated aging testing followed by simulated shipping distribution testing:
- Accelerated Aging Test ।
- Simulated shipping distribution testing -
- Visual inspection -
- Performance Inspection (Chemical performance and Physical performance) -
- Sterile Test -
- Vacuum Leak Test -
- Dye penetration test -
- Agar Contact-Attack Test -
- Tensile Seal Strength Test -
Clinical Performance Data
No clinical data was submitted in this submission.
Conclusions:
Based on the verification test results, the subject devices conform to the same applicable standards requirements such as performance and biocompatibility as the predicate device. The subject device uses the same fundamental scientific technology, same indications for use, sterilization methods, and the same shelf life and packaging. The differences do not raise new questions about the safety and effectiveness of the proposed device.
§ 880.5570 Hypodermic single lumen needle.
(a)
Identification. A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set.(b)
Classification. Class II (performance standards).